Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Deferred Taxes (2016 - 2017)

Wave Life Sciences (WVE) has disclosed Deferred Taxes for 3 consecutive years, with $4000.0 as the latest value for Q4 2017.

  • For the quarter ending Q4 2017, Deferred Taxes rose 100.46% year-over-year to $4000.0, compared with a TTM value of $908000.0 through Dec 2017, up 230.09%, and an annual FY2017 reading of $908000.0, up 230.09% over the prior year.
  • Deferred Taxes was $4000.0 for Q4 2017 at Wave Life Sciences, down from $772000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $772000.0 in Q3 2017 and bottomed at -$876000.0 in Q4 2016.
  • Average Deferred Taxes over 3 years is $20500.0, with a median of $48500.0 recorded in 2015.
  • Peak annual rise in Deferred Taxes hit 577.08% in 2017, while the deepest fall reached 3760.0% in 2017.
  • Year by year, Deferred Taxes stood at -$146000.0 in 2015, then crashed by 500.0% to -$876000.0 in 2016, then soared by 100.46% to $4000.0 in 2017.
  • Business Quant data shows Deferred Taxes for WVE at $4000.0 in Q4 2017, $772000.0 in Q3 2017, and $325000.0 in Q2 2017.